NCT05995613View on ClinicalTrials.gov

Evaluation of MABOS for Improved Pulse Oximeter Accuracy in Patients of Color

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

September 6, 2023

Primary Completion Date

January 15, 2024

Study Completion Date

February 1, 2024

Conditions
Oxygen Saturation
Interventions
DEVICE

MABOS

The novel pulse oximeter (MABOS) will be placed to acquire two biometrics: blood oxygen saturation and epidermal melanin concentration.

DEVICE

Nonin PureSat

An FDA approved pulse oximeter will be placed to acquire blood oxygen saturation.

Trial Locations (1)

27514

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT05995613 - Evaluation of MABOS for Improved Pulse Oximeter Accuracy in Patients of Color | Biotech Hunter | Biotech Hunter